SAC Capital Advisors’s Select Medical SEM Stock Holding History

SAC Capital Advisors’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-53,148	Closed	-$357K	–	843
2014 Q1	$357K	Buy	53,148 +34,495	+185%	+$209K	﹤0.01%	1329
2013 Q4	$117K	Buy	+18,653	New	+$91.1K	﹤0.01%	1707

Other funds holding SEM

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

SAC Capital Advisors's SEM Position: Q2 2014 in Review

SAC Capital Advisors sold out of Select Medical (SEM) in Q2 2014, closing a stake of 53,148 shares — an estimated $357K sold.

SAC Capital Advisors first reported a position in SEM in Q4 2013 and held it in 2 quarters. The position peaked at $357K in Q1 2014. 165 funds tracked by Wall St. Rank hold SEM as of Q2 2014.

SAC Capital Advisors reported no remaining Select Medical position as of Q2 2014 after selling out during the quarter.
SAC Capital Advisors sold 53,148 Select Medical shares in Q2 2014, an estimated $357K.
SAC Capital Advisors first reported a position in Select Medical in Q4 2013 and held it in 2 quarters.
SAC Capital Advisors's Select Medical position peaked at $357K in Q1 2014.
165 funds tracked by Wall St. Rank held Select Medical as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.